These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 21539455

  • 1. The tolerance and therapeutic efficacy of rhenium-188 hydroxyethylidene diphosphonate in advanced cancer patients with painful osseous metastases.
    Cheng A, Chen S, Zhang Y, Yin D, Dong M.
    Cancer Biother Radiopharm; 2011 Apr; 26(2):237-44. PubMed ID: 21539455
    [Abstract] [Full Text] [Related]

  • 2. Phase 2 study of a high dose of 186Re-HEDP for bone pain palliation in patients with widespread skeletal metastases.
    Pirayesh E, Amoui M, Mirzaee HR, Tabei F, Rakhsha A, Kalantari BA, Shafiei B, Assadi M, Asli IN.
    J Nucl Med Technol; 2013 Sep; 41(3):192-6. PubMed ID: 23918612
    [Abstract] [Full Text] [Related]

  • 3. Systemic radionuclide therapy in pain palliation.
    Liepe K, Runge R, Kotzerke J.
    Am J Hosp Palliat Care; 2005 Sep; 22(6):457-64. PubMed ID: 16323716
    [Abstract] [Full Text] [Related]

  • 4. Re-186(Sn) HEDP for treatment of painful osseous metastases: initial clinical experience in 20 patients with hormone-resistant prostate cancer.
    Maxon HR, Schroder LE, Thomas SR, Hertzberg VS, Deutsch EA, Scher HI, Samaratunga RC, Libson KF, Williams CC, Moulton JS.
    Radiology; 1990 Jul; 176(1):155-9. PubMed ID: 1693784
    [Abstract] [Full Text] [Related]

  • 5. Rhenium-188-HEDP therapy for the palliation of pain due to osseous metastases in lung cancer patients.
    Zhang H, Tian M, Li S, Liu J, Tanada S, Endo K.
    Cancer Biother Radiopharm; 2003 Oct; 18(5):719-26. PubMed ID: 14629820
    [Abstract] [Full Text] [Related]

  • 6. [186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast.
    Minutoli F, Herberg A, Spadaro P, Restifo Pecorella G, Baldari S, Aricò D, Altavilla G, Baldari S.
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):355-62. PubMed ID: 17043634
    [Abstract] [Full Text] [Related]

  • 7. [Clinical experience with rhenium-188 HEDP therapy for metastatic bone pain].
    Róka R, Séra T, Pajor L, Thurzó L, Láng J, Csernay L, Pávics L.
    Orv Hetil; 2000 May 07; 141(19):1019-23. PubMed ID: 10846424
    [Abstract] [Full Text] [Related]

  • 8. Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases.
    Palmedo H, Guhlke S, Bender H, Sartor J, Schoeneich G, Risse J, Grünwald F, Knapp FF, Biersack HJ.
    Eur J Nucl Med; 2000 Feb 07; 27(2):123-30. PubMed ID: 10755716
    [Abstract] [Full Text] [Related]

  • 9. Rhenium-186 hydroxyethylidene diphosphonate for the treatment of painful osseous metastases.
    Maxon HR, Thomas SR, Hertzberg VS, Schroder LE, Englaro EE, Samaratunga R, Scher HI, Moulton JS, Deutsch EA, Deutsch KF.
    Semin Nucl Med; 1992 Jan 07; 22(1):33-40. PubMed ID: 1375400
    [Abstract] [Full Text] [Related]

  • 10. Management of metastatic bone pain with repeated doses of rhenium 186-HEDP in patients under therapy with zoledronic acid: a safe and additively effective practice.
    Zafeirakis A, Zissimopoulos A, Baziotis N, Limouris GS.
    Cancer Biother Radiopharm; 2009 Oct 07; 24(5):543-50. PubMed ID: 19877884
    [Abstract] [Full Text] [Related]

  • 11. Palliative treatment of painful disseminated bone metastases with 186Rhenium-HEDP in patients with lung cancer.
    Leondi AH, Souvatzoglou MA, Rapti AS, Leontopoulou SA, Papadaki EK, Datseris EI, Anagnostopoulou US, Zerva CJ.
    Q J Nucl Med Mol Imaging; 2004 Sep 07; 48(3):211-9. PubMed ID: 15499295
    [Abstract] [Full Text] [Related]

  • 12. Palliative analgesic effect of Re-186 HEDP in various cancer patients with bone metastases.
    Küçük NO, Ibiş E, Aras G, Baltaci S, Ozalp G, Bedük Y, Canakci N, Soylu A.
    Ann Nucl Med; 2000 Aug 07; 14(4):239-45. PubMed ID: 11023023
    [Abstract] [Full Text] [Related]

  • 13. 186Re-HEDP for metastatic bone pain in breast cancer patients.
    Lam MG, de Klerk JM, van Rijk PP.
    Eur J Nucl Med Mol Imaging; 2004 Jun 07; 31 Suppl 1():S162-70. PubMed ID: 15118846
    [Abstract] [Full Text] [Related]

  • 14. Strontium 89 therapy for the palliation of pain due to osseous metastases.
    Robinson RG, Preston DF, Schiefelbein M, Baxter KG.
    JAMA; 1995 Aug 02; 274(5):420-4. PubMed ID: 7542352
    [Abstract] [Full Text] [Related]

  • 15. Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placebo.
    Maxon HR, Schroder LE, Hertzberg VS, Thomas SR, Englaro EE, Samaratunga R, Smith H, Moulton JS, Williams CC, Ehrhardt GJ.
    J Nucl Med; 1991 Oct 02; 32(10):1877-81. PubMed ID: 1717669
    [Abstract] [Full Text] [Related]

  • 16. The benefit of bone-seeking radiopharmaceuticals in the treatment of metastatic bone pain.
    Liepe K, Runge R, Kotzerke J.
    J Cancer Res Clin Oncol; 2005 Jan 02; 131(1):60-6. PubMed ID: 15449184
    [Abstract] [Full Text] [Related]

  • 17. Short- and long-term effects of 186Re-1,1-hydroxyethylidene diphosphonate in the treatment of painful bone metastases.
    Sciuto R, Tofani A, Festa A, Giannarelli D, Pasqualoni R, Maini CL.
    J Nucl Med; 2000 Apr 02; 41(4):647-54. PubMed ID: 10768566
    [Abstract] [Full Text] [Related]

  • 18. Serum hemoglobin levels predict response to strontium-89 and rhenium-186-HEDP radionuclide treatment for painful osseous metastases in prostate cancer.
    van der Poel HG, Antonini N, Hoefnagel CA, Horenblas S, Valdes Olmos RA.
    Urol Int; 2006 Apr 02; 77(1):50-6. PubMed ID: 16825816
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Rhenium-188 HEDP to treat painful bone metastases.
    Li S, Liu J, Zhang H, Tian M, Wang J, Zheng X.
    Clin Nucl Med; 2001 Nov 02; 26(11):919-22. PubMed ID: 11595844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.